Organization · Venture Capital
Diamond BioFund Inc. / Diamond Capital Inc.
Diamond BioFund Inc. is a Taipei-based venture capital firm focused on biotechnology investments, managing assets of approximately $250-313 million. It is recognized as the first publicly listed evergreen venture capital firm in Taiwan.
Overview
What Diamond BioFund Inc. / Diamond Capital Inc. does
What Diamond BioFund Inc. / Diamond Capital Inc. is
Diamond BioFund Inc. is a Taipei-based venture capital firm focused on biotechnology investments, managing assets of approximately $250-313 million. It is recognized as the first publicly listed evergreen venture capital firm in Taiwan.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2013
- Approximate age
- About 13 years
- Structured capabilities
- Funder
- Last reviewed
- April 30, 2026
Official channels
Find Diamond BioFund Inc. / Diamond Capital Inc. elsewhere
Open the official website or a supported primary organization account.
Capability profile
Diamond BioFund Inc. / Diamond Capital Inc. as a funder
Investment thesis
Diamond BioFund aims to leverage evergreen capital and a specialized life-sciences team to support globally competitive biotech companies, focusing on new drug development, high-end medical equipment, and agricultural biotechnology.
Focus narrative
Diamond BioFund specializes in early-stage biotech startups and mid-to-late-stage biotech products, with a commitment to supporting the development of innovative medical solutions. The firm seeks to facilitate the entry of Taiwan's biotech innovations into global markets, particularly the US and EU, while also engaging in mergers and acquisitions to enhance its portfolio.
Value beyond capital
Diamond BioFund provides its portfolio companies with access to a specialized team with expertise in clinical development, capital markets, and M&A pathways. The firm emphasizes global market entry support and risk management across the biotech value chain, aiming to enhance the commercialization potential of its investments.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Series D · Growth Equity
- Sectors
- Biotech · Healthcare · Medical Devices · Digital Health
- Regions
- Global · United States · Eu
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Sinew Pharma Inc.
Portfolio context
Rejuvenate Bio: A gene-therapy company focused on longevity biotechnology. Ativa Medical: A women-founded medical company recognized for its diversity initiatives. Sinew Pharma Inc.: A biopharma company specializing in hepatic enzymes and integrated new-drug R&D. University/Institute Spin-offs: Diamond has cultivated several biotech spin-offs from top-tier universities and research institutes in Taiwan.
Common questions
What to know about Diamond BioFund Inc. / Diamond Capital Inc.
Upseed classifies Diamond BioFund Inc. / Diamond Capital Inc. under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.